Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial
Top Cited Papers
Open Access
- 14 March 2017
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 18 (5), 654-662
- https://doi.org/10.1016/s1470-2045(17)30109-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Meta-analysis of stomatitis in clinical studies of everolimus: incidence and relationship with efficacyAnnals of Oncology, 2016
- Stomatitis Associated With Use of mTOR Inhibitors: Implications for Patients With Invasive Breast CancerClinical Journal of Oncology Nursing, 2015
- Incidence and Risk of High-grade Stomatitis with mTOR Inhibitors in Cancer PatientsCancer Investigation, 2015
- Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2Annals of Oncology, 2014
- Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival AnalysisAdvances in Therapy, 2013
- Oral ulcers in patients with advanced breast cancer receiving everolimus: a case series report on clinical presentation and managementOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2013
- The Design of Single-Arm Clinical Trials of Combination Antiretroviral Regimens for Treatment-Naive HIV-Infected PatientsAIDS Research and Human Retroviruses, 2013
- Clinical presentation and management of mTOR inhibitor-associated stomatitisOral Oncology, 2011
- Managing Stomatitis in Patients Treated With Mammalian Target of Rapamycin InhibitorsClinical Journal of Oncology Nursing, 2011
- Examining the validity of pressure ulcer risk assessment scales: developing and using illustrated patient simulations to collect the data INFORMATION POINT: Visual Analogue ScaleJournal of Clinical Nursing, 2001